Trisequens is a sequential combined hormone replacement therapy (HRT) designed for postmenopausal women who still have a uterus. It effectively treats common menopausal symptoms such as hot flushes, night sweats, mood swings, and vaginal dryness. It is also used to help prevent osteoporosis in women at risk who cannot take other treatments.
How It Works
Trisequens contains two hormones: estradiol (a form of oestrogen) and norethisterone acetate (a synthetic progestogen). The tablets are taken in a specific sequence over 28 days—blue tablets (oestrogen only), white tablets (combined), and red tablets (combined). This phased delivery replenishes declining hormone levels while protecting the endometrium from overgrowth. The sequential regimen closely mimics natural hormonal fluctuations and typically results in monthly withdrawal bleeding.
Why Choose Trisequens
Trisequens is ideal for women who prefer a structured, cyclical HRT plan. The pack design supports clear adherence to the correct sequence. It is particularly helpful in the early stages of menopause when natural hormonal rhythms are still transitioning. With a trusted formulation and proven efficacy, Trisequens supports improved quality of life for women experiencing moderate to severe menopausal symptoms.
Important Note
Trisequens is not suitable for all women. It must not be used in those with a history of hormone-dependent cancers, blood clots, liver disorders, or unexplained vaginal bleeding. Before initiating treatment, a full medical evaluation is necessary. Ongoing review and regular monitoring by your doctor are essential.
